• No osteoporosis was observed in either case group or control group. The prevalence of osteopenia was 7.3% versus 1.7% among the cases compared to controls.
Background
• Bone loss may be up to 3 times more common among people with HIV than in the general population. 1 • The traditional risk factors for bone loss including low body weight, smoking, and drinking alcohol are more common in the HIV populations. 2 • However, it remains unknown the contribution of these factors to bone loss as well as how HIV itself is associated with the risk of bone loss.
Objectives
• To estimate the prevalence of osteopenia/osteoporosis among HIV-positive adults ages 18-49 versus matched HIVnegative adults • To rank predictors for osteopenia/osteoporosis in terms of their contribution to a prediction model.
Conclusions
• HIV itself is a significant predictor for osteopenia; but due to lack of information on treatment history, it remains unclear if HIV medicine or treatment duration can increase the risk of osteopenia.
Limitations
• No follow-up data are available in the NHANES database, so the predictors do not necessarily mean risk factors.
• Some important variables were not included in the model due to lack of enough observations, such as calcium/vitamin D intake, concurrent medication, and family income. 
Outcomes
• Bone mineral density (BMD) T-score of femur neck was calculated based on the mean and SD from data for nonHispanic white females ages 20-29 from the NHANES III.
• Osteopenia was defined as T-score between -1 and -2.5
• Osteoporosis was defined as T-score less than -2.5.
Candidate Predictors
• HIV testing result
• Body mass index (BMI)
• Alcohol drinking
• Smoking status
• Physical activity intensity
• Family history of osteoporosis
• Education
• Marital status
Data Analysis
• The prevalence of osteopenia/osteoporosis among all identified HIV-positive adults and among the matched cohort were calculated with adjusting sampling weights.
• A HIV-positive adult was matched with 3 HIV-negative adults at the same sex, age category and race.
• Stepwise multiple logistic regression identified predictors of osteopenia/osteoporosis among the matched cohort.
Abstract
OBJECTIVES: Bone loss is a common problem occurring among human immunodeficiency virus (HIV)-positive patients. Explanations for the bone loss are unknown. We estimated the prevalence of osteopenia among HIV-positive adults ages 18-49 versus matched HIV-negative adults; and ranked predictors for osteopenia in terms of their contribution to a prediction model.
METHODS:
We conducted a cross-sectional study on the 2005-2010 National Health and Nutrition Examination Survey (NHANES). HIV-positive individuals were identified according to HIV antibody test. Bone mineral density (BMD) T-score of femur neck was calculated based on the mean and SD from data for non-Hispanic white females ages 20-29 from the NHANES III. Osteopenia was defined as T-score between -1 and -2.5; osteoporosis was defined as T-score less than -2.5. A HIVpositive adult was matched with 3 HIV-negative adults at the same sex, age category and race. We used multiple logistic regression identified predictors of osteopenia among the matched cohort.
RESULTS: 52 HIV-positive individuals were identified. In the matched cohort 46 HIV-positive and 138 HIV-negative adults were included. The mean age of the matched cohort was 39.3±9.0 years, and 76.1% were male. No osteoporosis was observed in either case group or control group. The prevalence of osteopenia was 7.3% versus 1.7% among the cases compared to controls. Osteopenia occurred only among males in the cases and females in the controls. Alcohol consumption (p<0.0001) was the strongest predictor of osteopenia, followed by activity intensity (p=0.0003), family history of osteoporosis (p=0.0007), and HIV itself (p=0.0026), after controlling BMI and smoking status.
CONCLUSIONS:
HIV itself is a significant predictor for osteopenia; but due to lack of information on treatment history, it remains unclear if HIV medicine or treatment duration can increase the risk of osteopenia. 
